ResearcherChangzhou No.2 People's HospitalActive in the last 2 years
Xihu Qin
Matched on ORCID iD 0000-0002-0256-3478; OpenAlex author ID A5006929184. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- tRF-Pro-CGG Suppresses Cell Proliferation and Promotes Apoptosis in Pancreatic Cancer. Last author DOI 10.1007/s10620-025-08943-x↗
- Insight into the effects of microRNA-23a-3p on pancreatic cancer and its underlying molecular mechanism. Last author DOI 10.3892/ol.2019.11117↗
- Expression profile of tRNA-derived fragments in pancreatic cancer. Last author DOI 10.3892/ol.2019.10601↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lei Jin · 3 shared papers, 2019–2025 · strength 0.51
- Paper tRF-Pro-CGG Suppresses Cell Proliferation and Promotes Apoptosis in Pancreatic Cancer. DOI 10.1007/s10620-025-08943-x↗
- Paper Expression profile of tRNA-derived fragments in pancreatic cancer. DOI 10.3892/ol.2019.10601↗
- Paper Insight into the effects of microRNA-23a-3p on pancreatic cancer and its underlying molecular mechanism. DOI 10.3892/ol.2019.11117↗
- Chunfu Zhu · 3 shared papers, 2019–2025 · strength 0.51
- Paper tRF-Pro-CGG Suppresses Cell Proliferation and Promotes Apoptosis in Pancreatic Cancer. DOI 10.1007/s10620-025-08943-x↗
- Paper Expression profile of tRNA-derived fragments in pancreatic cancer. DOI 10.3892/ol.2019.10601↗
- Paper Insight into the effects of microRNA-23a-3p on pancreatic cancer and its underlying molecular mechanism. DOI 10.3892/ol.2019.11117↗
- Jiadeng Chao · 2 shared papers, 2020–2025 · strength 0.34
- Cailin Xue · 1 shared paper, 2025 · strength 0.25
- Jikuan Zhu · 1 shared paper, 2025 · strength 0.25
- Jun Li · 1 shared paper, 2025 · strength 0.25
- Jun Li · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.